Skip to content
Screener

R&D at other companies

Cadence Design Systems logo
Cadence Design SystemsCDNS
$531.27M+20.2%
Simulations Plus logo
Simulations PlusSLP
$3.41M+180%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$89.61M-30.3%
Absci Corporation logo
Absci CorporationABSI
$22.62M+10.5%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$45.99M+17.3%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$76.48M+19.7%

Other financials

Income statement

See full
Revenue$58.9M+7.5%
Gross profit$32.4M+24.0%
Operating income-$41.5M+21.5%
Net income$6.0M+114%
EPS (diluted)$0.08+114%

Balance sheet

See full
Cash & equivalents$292.9M+26.3%
Total debt$108.0M-5.5%
Total equity$329.0M-4.1%
Total assets$640.4M-7.0%

Cash flow

See full
Operating cash flow-$34.1M
CapEx$362.0K+15.3%
Free cash flow-$34.4M

Valuation

See full
Market cap$1.36B+2.4%
Enterprise value$1.17B-2.7%
P/S5.2×-0.3×

Profitability

See full
Gross margin56.9%-1.6pp
Operating margin-59.2%-12.6pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.6×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Schrodinger’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:08 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001490978-26-000068
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total cost of revenues26,45728,60155,49757,028
Gross profit32,43226,15861,97957,282
Operating expenses:
Research and development40,99843,13884,82288,982
Sales and marketing10,26610,73421,86921,101
General and administrative (includes related party expense of $165, $109, $330 and $218)22,71525,18945,62950,991
Total operating expenses73,97979,061152,320161,074
Loss from operations(41,547)(52,903)(90,341)(103,792)

Item 1. Financial Statements.

FAQ

What is Schrodinger's R&D?
Schrodinger (SDGR) reported R&D of $41M in Q2 2026.
How has Schrodinger's R&D changed year-over-year?
Schrodinger's R&D decreased by 5.0% year-over-year, from $43.14M to $41M.
What is the long-term trend for Schrodinger's R&D?
Over 4 years (2021 to 2025), Schrodinger's R&D has grown at a 17.5% compound annual growth rate (CAGR), from $90.9M to $173.14M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ask your AI about Schrodinger's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude